GFAP and Alzheimer disease: GFAP expression is upregulated in AD [78], with A1 astrocytes forming the main population of the reactive cells in humans [82], consistent with a previous study highlighting variation in the pattern of GFAP, EAAT1, EAAT2, and S100B in relation to AD pathology [94].